CUSIP: 629444209
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
23,771,791
-
Total 13F shares
-
5,235,517
-
Share change
-
+1,263,887
-
Total reported value
-
$14,169,868
-
Price per share
-
$2.71
-
Number of holders
-
28
-
Value change
-
+$3,242,026
-
Number of buys
-
13
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 629444209?
CUSIP 629444209 identifies NRXP - NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP 629444209:
Institutional Holders of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) as of Q4 2025
As of 31 Dec 2025,
NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,235,517 shares.
The largest 10 holders included
Anson Funds Management LP, VANGUARD GROUP INC, COMMONWEALTH EQUITY SERVICES, LLC, AdvisorShares Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, Bleakley Financial Group, LLC, STATE STREET CORP, BlackRock, Inc., Global Retirement Partners, LLC, and JANE STREET GROUP, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.